End-of-day quote
INDONESIA S.E.
04:30:00 19/03/2024 am IST
|
5-day change
|
1st Jan Change
|
1,715
IDR
|
+3.63%
|
|
-.--%
|
+471.67%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
30,48,179
|
32,16,189
|
24,48,144
|
37,20,219
|
78,60,462
|
36,00,212
|
Enterprise Value (EV)
1 |
29,60,105
|
32,37,155
|
39,76,005
|
53,79,551
|
99,79,738
|
62,47,480
|
P/E ratio
|
-31.9
x
|
-42.5
x
|
-170
x
|
22.5
x
|
-177
x
|
-93.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.78
x
|
3.21
x
|
1.91
x
|
1.93
x
|
4.06
x
|
1.44
x
|
EV / Revenue
|
3.67
x
|
3.23
x
|
3.1
x
|
2.8
x
|
5.16
x
|
2.5
x
|
EV / EBITDA
|
-567
x
|
221
x
|
35.3
x
|
13.7
x
|
44.1
x
|
17.3
x
|
EV / FCF
|
321
x
|
-27.2
x
|
-8.05
x
|
-1,065
x
|
-22.2
x
|
-11.5
x
|
FCF Yield
|
0.31%
|
-3.67%
|
-12.4%
|
-0.09%
|
-4.5%
|
-8.69%
|
Price to Book
|
1.66
x
|
1.81
x
|
1.4
x
|
1.93
x
|
4.15
x
|
1.94
x
|
Nbr of stocks (in thousands)
|
1,20,00,705
|
1,20,00,705
|
1,20,00,705
|
1,20,00,705
|
1,20,00,705
|
1,20,00,705
|
Reference price
2 |
254.0
|
268.0
|
204.0
|
310.0
|
655.0
|
300.0
|
Announcement Date
|
01/04/19
|
09/05/20
|
09/06/21
|
25/03/22
|
30/03/23
|
01/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
8,06,031
|
10,02,002
|
12,83,799
|
19,24,453
|
19,34,164
|
25,03,174
|
EBITDA
1 |
-5,222
|
14,680
|
1,12,571
|
3,91,314
|
2,26,422
|
3,60,990
|
EBIT
1 |
-85,303
|
-61,032
|
9,568
|
2,41,799
|
26,364
|
1,05,145
|
Operating Margin
|
-10.58%
|
-6.09%
|
0.75%
|
12.56%
|
1.36%
|
4.2%
|
Earnings before Tax (EBT)
1 |
-96,978
|
-66,323
|
191.4
|
1,56,420
|
-42,087
|
-31,291
|
Net income
1 |
-95,419
|
-75,670
|
-14,381
|
1,65,308
|
-44,315
|
-38,490
|
Net margin
|
-11.84%
|
-7.55%
|
-1.12%
|
8.59%
|
-2.29%
|
-1.54%
|
EPS
2 |
-7.951
|
-6.305
|
-1.198
|
13.77
|
-3.693
|
-3.207
|
Free Cash Flow
1 |
9,224
|
-1,18,914
|
-4,93,965
|
-5,052
|
-4,49,095
|
-5,42,620
|
FCF margin
|
1.14%
|
-11.87%
|
-38.48%
|
-0.26%
|
-23.22%
|
-21.68%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
01/04/19
|
09/05/20
|
09/06/21
|
25/03/22
|
30/03/23
|
01/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
20,966
|
15,27,861
|
16,59,333
|
21,19,276
|
26,47,268
|
Net Cash position
1 |
88,074
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
1.428
x
|
13.57
x
|
4.24
x
|
9.36
x
|
7.333
x
|
Free Cash Flow
1 |
9,224
|
-1,18,914
|
-4,93,965
|
-5,052
|
-4,49,095
|
-5,42,620
|
ROE (net income / shareholders' equity)
|
-5.51%
|
-4.19%
|
-0.82%
|
8.99%
|
-2.31%
|
-2.04%
|
ROA (Net income/ Total Assets)
|
-2.18%
|
-1.3%
|
0.16%
|
3.28%
|
0.31%
|
1.16%
|
Assets
1 |
43,80,413
|
58,01,119
|
-89,65,478
|
50,41,730
|
-1,42,85,928
|
-33,25,845
|
Book Value Per Share
2 |
153.0
|
148.0
|
146.0
|
161.0
|
158.0
|
155.0
|
Cash Flow per Share
2 |
18.70
|
19.30
|
52.50
|
58.40
|
93.20
|
42.90
|
Capex
1 |
4,09,563
|
3,85,242
|
5,44,122
|
4,64,023
|
6,55,547
|
5,83,532
|
Capex / Sales
|
50.81%
|
38.45%
|
42.38%
|
24.11%
|
33.89%
|
23.31%
|
Announcement Date
|
01/04/19
|
09/05/20
|
09/06/21
|
25/03/22
|
30/03/23
|
01/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +471.67% | 127.71Cr | | +17.18% | 8.31TCr | | -28.48% | 7.09TCr | | +6.76% | 2.83TCr | | -7.44% | 1.77TCr | | +2.14% | 1.74TCr | | +2.10% | 1.56TCr | | +7.02% | 1.35TCr | | +64.96% | 1.27TCr | | +6.64% | 1.28TCr |
Other Healthcare Facilities & Services
|